Molecules 2001, 6(3), 142-193; doi:10.3390/60300142

Muscarinic Receptor Agonists and Antagonists

1 and 2,* email
Received: 2 May 2000; in revised form: 16 January 2001 / Accepted: 16 January 2001 / Published: 28 February 2001
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholine agonists and antagonists is presented. The therapeutic benefits of achieving receptor subtype selectivity are outlined and applications in the treatment of Alzheimer’s disease are discussed. A selection of chemical routes are described, which illustrate contemporary methodology for the synthesis of chiral medicinal compounds (asymmetric synthesis, chiral pool, enzymes). Routes to bicyclic intrannular amines and intramolecular Diels-Alder reactions are highlighted.
Keywords: Alzheimer’s disease; nicotine; acetylcholine; arecoline; himbacine; tacrine; cyclostelletamines; intramolecular Diels-Alder reaction; indole alkaloids
PDF Full-text Download PDF Full-Text [320 KB, uploaded 18 June 2014 19:25 CEST]

Export to BibTeX |

MDPI and ACS Style

Broadley, K.J.; Kelly, D.R. Muscarinic Receptor Agonists and Antagonists. Molecules 2001, 6, 142-193.

AMA Style

Broadley KJ, Kelly DR. Muscarinic Receptor Agonists and Antagonists. Molecules. 2001; 6(3):142-193.

Chicago/Turabian Style

Broadley, Kenneth J.; Kelly, David R. 2001. "Muscarinic Receptor Agonists and Antagonists." Molecules 6, no. 3: 142-193.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert